176 related articles for article (PubMed ID: 6562280)
21. Comparison of two hemodialysis membranes, polyacrylonitrile and cellulose acetate, on complement and coagulation systems.
Moll S; De Moerloose P; Reber G; Schifferli J; Leski M
Int J Artif Organs; 1990 May; 13(5):273-9. PubMed ID: 2142140
[TBL] [Abstract][Full Text] [Related]
22. Effects of complement activation by hemodialysis membranes.
Cheung AK; Henderson LW
Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
[No Abstract] [Full Text] [Related]
23. [The effect of the primary and repeated use of dialyzers with different membranes on the degree of dialysis-induced leukopenia].
Strokov AG; Baeva LB; Levitskiĭ ER
Med Tekh; 1990; (5):16-8. PubMed ID: 2273963
[TBL] [Abstract][Full Text] [Related]
24. Symptoms and activation of granulocytes and complement with two dialysis membranes.
Ivanovich P; Chenoweth DE; Schmidt R; Klinkmann H; Boxer LA; Jacob HS; Hammerschmidt DE
Kidney Int; 1983 Dec; 24(6):758-63. PubMed ID: 6609268
[TBL] [Abstract][Full Text] [Related]
25. Leukocytes, eosinophils and complement function during hemodialysis with polysulphone and polymethylmethacrylate membranes: comparison with cuprophan and polyacrylonitrile.
Bergesio F; Monzani G; Manescalchi F; Boccabianca I; Passaleva A; Frizzi V
Blood Purif; 1988; 6(1):16-26. PubMed ID: 3345242
[TBL] [Abstract][Full Text] [Related]
26. In vitro activation of human complement by polyacrilonitrile dialyzer membrane assayed by complement binding to bystander red cells.
Shastri KA; Logue GL
ASAIO J; 1992; 38(1):47-51. PubMed ID: 1554917
[TBL] [Abstract][Full Text] [Related]
27. Membrane biocompatibility: clinical significance and therapeutic implications.
Dumler F; Levin NW
Int J Artif Organs; 1985 Sep; 8(5):257-62. PubMed ID: 3910591
[No Abstract] [Full Text] [Related]
28. Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes.
Woffindin C; Hoenich NA
Biomaterials; 1988 Jan; 9(1):53-7. PubMed ID: 3126842
[TBL] [Abstract][Full Text] [Related]
29. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
[TBL] [Abstract][Full Text] [Related]
30. Compartmental distribution of complement activation products in artificial kidneys.
Cheung AK; Chenoweth DE; Otsuka D; Henderson LW
Kidney Int; 1986 Jul; 30(1):74-80. PubMed ID: 3489123
[TBL] [Abstract][Full Text] [Related]
31. Abnormal leucocyte locomotion induced by haemodialysis membranes. A clue to dialysis leucopenia.
Losito A; Buoncristiani U; Cecchini C
J Clin Lab Immunol; 1983 Feb; 10(2):87-90. PubMed ID: 6601717
[TBL] [Abstract][Full Text] [Related]
32. Effect of regional citrate anticoagulation on leukopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes.
Dhondt A; Vanholder R; Tielemans C; Glorieux G; Waterloos MA; De Smet R; Lameire N
Nephron; 2000 Aug; 85(4):334-42. PubMed ID: 10940744
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
34. Biocompatibility criteria in hemodialysis.
Cordonnier DJ; Forêt M
Contrib Nephrol; 1989; 71():30-5. PubMed ID: 2680263
[No Abstract] [Full Text] [Related]
35. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
Schaefer RM; Hörl WH; Kokot K; Heidland A
Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
[TBL] [Abstract][Full Text] [Related]
36. Complement activation in haemodialysis: a comparison of new and re-used dialysers.
Levett DL; Woffindin C; Bird AG; Hoenich NA; Ward MK; Kerr DN
Int J Artif Organs; 1986 Mar; 9(2):97-104. PubMed ID: 3699916
[TBL] [Abstract][Full Text] [Related]
37. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
Orłowski A; Szepietowski T
Polim Med; 1992; 22(1-2):59-72. PubMed ID: 1461837
[TBL] [Abstract][Full Text] [Related]
38. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
[TBL] [Abstract][Full Text] [Related]
39. Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis.
Ward RA; Schaefer RM; Falkenhagen D; Joshua MS; Heidland A; Klinkmann H; Gurland HJ
Nephrol Dial Transplant; 1993; 8(1):47-53. PubMed ID: 8381935
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of a new high-flux cellulose acetate membrane.
Schaefer RM; Huber L; Gilge U; Bausewein K; Vienken J; Heidland A
Int J Artif Organs; 1989 Feb; 12(2):85-90. PubMed ID: 2651325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
